RxDoctor Payments Data

Nirmish Singla, MD

Urology · Baltimore, MDNPI 1447510912

Payments from drug & device makers

What this record shows

15 manufacturers reported payments, led by Histosonics, Inc. at 51.6% of the total. Reporting peaked in 2024 at $1,979 and has fallen 89.5% since, to $207 in 2025. That places this record below the midpoint for urology clinicians in MD, where the typical reported total is $4,190.

$3,302in general payments, 2019–2025

Across 39 payments — averaging $84.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Histosonics, Inc.$2K
  • Medtronic$381
  • Urogen Pharma, Inc.$323
  • Intuitive Surgical$192
  • Merck$128
  • Olympus America Inc.$115
  • plus $458 from 9 others
$26,012in research payments, 2019–2025

Across 2 payments — averaging $13,006 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Urogen Pharma, Inc.$17K
  • Histosonics, Inc.$9K

What the payments were for

  • Travel & lodging$1,65650%
  • Food & beverage$1,64650%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,302 in reported general payments places this provider in the 45th percentile of 274 urology providers in Maryland.

See all urology providers in Maryland

Medicare billing

Part B allowed, 2024
$146,537
Medicare patients
247
Services billed
558

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fesoterodine Fumarate ErFesoterodine Fumarate24$900
Tamsulosin Hcl13$163

Paid to pharmacies, not to this prescriber.

Other urology in Baltimore

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →